Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Study finds rise in volumes and survival after hematopoietic cell transplants among racial/ethnic minorities

Study finds rise in volumes and survival after hematopoietic cell transplants among racial/ethnic minorities

Research highlights emergence of immune-evasive SARS-CoV-2 variants in immunocompromised patients

Research highlights emergence of immune-evasive SARS-CoV-2 variants in immunocompromised patients

Research unveils bispecific antibodies for B-cell lymphoma treatment

Research unveils bispecific antibodies for B-cell lymphoma treatment

Heart transplant recipient's journey: From patient to advocate

Heart transplant recipient's journey: From patient to advocate

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

Novel therapeutic approach identified for overcoming resistance in B-cell leukemia

Novel therapeutic approach identified for overcoming resistance in B-cell leukemia

ACE inhibitors show no benefit in reducing chemotherapy-induced heart damage

ACE inhibitors show no benefit in reducing chemotherapy-induced heart damage

Therapeutic potential of CD20 x CD3 bispecific antibodies

Therapeutic potential of CD20 x CD3 bispecific antibodies

Eating soy products linked to lower cancer risk, study finds

Eating soy products linked to lower cancer risk, study finds

Researchers discover key drivers behind follicular lymphoma's aggressive transformation

Researchers discover key drivers behind follicular lymphoma's aggressive transformation

Longer durations of breastfeeding lowers the risk of childhood cancers

Longer durations of breastfeeding lowers the risk of childhood cancers

Research from NY highlights pollution as a key factor in rising cancer rates among youth

Research from NY highlights pollution as a key factor in rising cancer rates among youth

Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

Study reveals genetic variant linked to increased risk of leukemia in Hispanic/Latino children

Study reveals genetic variant linked to increased risk of leukemia in Hispanic/Latino children

Scientists uncover four proteins that govern the identity of anaplastic large cell lymphoma

Scientists uncover four proteins that govern the identity of anaplastic large cell lymphoma

Groundbreaking atlas maps over 80 blood stem cell types

Groundbreaking atlas maps over 80 blood stem cell types

Study highlights global fertility decline and its implications for the future

Study highlights global fertility decline and its implications for the future

MRI and lumbar puncture may not be necessary for managing CAR T-cell associated toxicities

MRI and lumbar puncture may not be necessary for managing CAR T-cell associated toxicities

DNA origami vaccine DoriVac paves way for personalized cancer immunotherapy

DNA origami vaccine DoriVac paves way for personalized cancer immunotherapy

Computer model can find signs of lymph node cancer in 90% of cases

Computer model can find signs of lymph node cancer in 90% of cases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.